Data From 2023 ASH Annual Meeting Provide Positive Updates in Multiple Myeloma : vimarsana.com

Experts discuss treatment in newly diagnosed multiple myeloma and the role of CAR T-cell therapies and bispecifics in relapsed/refractory disease.

Related Keywords

California , United States , Illinois , San Diego , Chicago , American , Caitlin Costello , Krinak Patel , American Society Of Clinical Oncology Annual Meeting , Onclive Peer Exchange , American Society Of Hematology Annual Meeting Exposition , American Society , Hematology Annual Meeting , Newly Diagnosed Multiple , Cell Therapy , Refractory Multiple , Clinical Oncology Annual Meeting , Cart Cell Therapies , Bispecifics In Relapsed Refractory Disease , Newly Diagnosed Multiple Myeloma ,